Integral Derivatives’s Gilead Sciences GILD Stock Holding History

Integral Derivatives’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3.02M	Sell	40,000 -26,600	-40%	-$2.11M	0.07%	80
2017 Q4	$4.77M	Buy	66,600 +3,700	+6%	+$281K	0.09%	126
2017 Q3	$5.1M	Sell	62,900 -2,600	-4%	-$199K	0.09%	136
2017 Q2	$4.64M	Buy	65,500 +10,700	+20%	+$712K	0.1%	121
2017 Q1	$3.72M	Sell	54,800 -41,000	-43%	-$2.88M	0.07%	181
2016 Q4	$6.86M	Buy	95,800 +50,000	+109%	+$3.72M	0.13%	100
2016 Q3	$3.62M	Sell	45,800 -41,300	-47%	-$3.35M	0.08%	154
2016 Q2	$7.27M	Buy	87,100 +22,500	+35%	+$2M	0.18%	74
2016 Q1	$5.93M	Sell	64,600 -29,700	-31%	-$2.68M	0.19%	72
2015 Q4	$9.54M	Buy	94,300 +44,000	+87%	+$4.58M	0.24%	64
2015 Q3	$4.94M	Sell	50,300 -39,000	-44%	-$4.33M	0.14%	118
2015 Q2	$10.5M	Sell	89,300 -41,500	-32%	-$4.53M	0.29%	56
2015 Q1	$12.8M	Buy	130,800 +62,400	+91%	+$6.34M	0.27%	41
2014 Q4	$6.45M	Sell	68,400 -27,300	-29%	-$2.82M	0.11%	151
2014 Q3	$10.2M	Buy	95,700 +63,700	+199%	+$6.24M	0.18%	85
2014 Q2	$2.65M	Sell	32,000 -18,300	-36%	-$1.42M	0.05%	326
2014 Q1	$3.56M	Sell	50,300 -3,400	-6%	-$267K	0.07%	258
2013 Q4	$4.04M	Buy	+53,700	New	+$3.74M	0.06%	282

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integral Derivatives's GILD Position: Q1 2018 in Review

Integral Derivatives increased its Gilead Sciences (GILD) stake by 257% in Q1 2018, buying an estimated $1.78M and bringing the position to 31,187 shares worth $2.35M. The position accounts for 0.06% of the portfolio, ranked #104.

Integral Derivatives first reported a position in GILD in Q4 2013 and has held it in 16 quarters since. The position peaked at $10M in Q2 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

Integral Derivatives held 31,187 shares of Gilead Sciences worth $2.35M as of Q1 2018.
Integral Derivatives bought 22,443 Gilead Sciences shares in Q1 2018, an estimated $1.78M.
Gilead Sciences made up 0.06% of Integral Derivatives's portfolio in Q1 2018, its #104 holding.
Integral Derivatives first reported a position in Gilead Sciences in Q4 2013 and has held it in 16 quarters since.
Integral Derivatives's Gilead Sciences position peaked at $10M in Q2 2015.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.